The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0255
Bid: 0.024
Ask: 0.027
Change: 0.00 (0.00%)
Spread: 0.003 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0255
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of General Meeting

30 Dec 2021 13:51

RNS Number : 0913X
Supply @ME Capital PLC
30 December 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

30 December 2021

 

Supply@ME Capital plc

(The "Company", "the Group" or "SYME")

Outcome of General Meeting

A General Meeting of Supply@ME Capital plc, the innovative fintech platform (the "Platform"), which provides the Inventory Monetisation© service to manufacturing and trading companies, was duly convened earlier today (the "Meeting").

The Meeting was held to enable shareholders to consider whether any, and if so, what steps should be taken to address the Company's "serious loss of capital" as defined and required by section 656(1) of the Companies Act 2006. Details of the largely historical situation which resulted in this position were set out in the formal Notice of General Meeting and the Company's RNS of 7 December 2021.

Following discussions at today's Meeting, it was concluded that the Company's anticipated increase in revenues commencing in 2022 from each of the three revenue streams (per the definitions introduced in the RNS of 31 August 2021), which includes the positive impacts generated by the completion of the first inventory monetisation transactions and the acquisition of TradeFlow Capital Management Pte. Ltd, will contribute towards alleviating the loss of capital. The "serious loss of capital" does not itself have any specific bearing on the Company's current financial position or current trading performance.

The Company also intends to issue a trading update, covering the second half of 2021, tomorrow, 31 December 2021.

Shareholders were not asked to vote at the general meeting as it was a discussion forum only.

The board of SYME always welcomes dialogue with shareholders and today's General Meeting provided a suitable forum for discussions on this issue to take place.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the directors of the Company are responsible for the release of this announcement.

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/ export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This programme will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories.

 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780, paul.vann@walbrookpr.com 

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317, brian.norris@cicero-group.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFSVFTLIVIL
Date   Source Headline
12th Apr 20235:38 pmRNSNotification of Transaction of a PCA
3rd Apr 202311:52 amRNSTotal Voting Rights
28th Mar 202311:05 amRNSSecond Price Monitoring Extn
28th Mar 202311:00 amRNSPrice Monitoring Extension
24th Mar 20234:40 pmRNSSecond Price Monitoring Extn
24th Mar 20234:35 pmRNSPrice Monitoring Extension
24th Mar 20237:30 amRNSBoard changes and TradeFlow update
20th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSDirectorate Change
3rd Mar 20234:32 pmRNSHolding(s) in Company
2nd Mar 20237:12 amRNSExercise of Warrants, issue of equity and TVR
1st Mar 20232:05 pmRNSSecond Price Monitoring Extn
1st Mar 20232:00 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSTotal Voting Rights
8th Feb 20235:07 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSTotal Voting Rights
31st Jan 20234:40 pmRNSSecond Price Monitoring Extn
31st Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
24th Jan 20238:00 amRNSPublication of new Italian PNP regulation
20th Jan 20237:00 amRNSYear-end business update
10th Jan 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
30th Dec 202212:40 pmRNSSecond Price Monitoring Extn
30th Dec 202212:35 pmRNSPrice Monitoring Extension
30th Dec 20227:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSStrategic Alliance with VeChain Foundation
1st Dec 20227:00 amRNSExercise of Warrants, Issue of Equity & TVR
30th Nov 20227:00 amRNSTotal Voting Rights
22nd Nov 20227:00 amRNSExercise of Warrants, Issue of Equity, and TVR
7th Nov 20227:00 amRNSExercise of Warrants, Issue of Equity &TVR
2nd Nov 20227:00 amRNSGrant of Awards under Long Term Incentive Plan
2nd Nov 20227:00 amRNSTotal Voting Rights - Replacement
31st Oct 20223:07 pmRNSTotal Voting Rights
21st Oct 20222:01 pmRNSRepayment of Mercator Facility in Cash
21st Oct 20227:00 amRNSIssue of Equity
18th Oct 20225:51 pmRNSHolding in Company
14th Oct 20225:38 pmRNSHolding in Company
13th Oct 20227:00 amRNSNew Banking Facility
11th Oct 20228:00 amRNSHolding in Company
10th Oct 20227:00 amRNSAdmission of New Shares and Total Voting Rights
7th Oct 20221:30 pmRNSHolding in Company
3rd Oct 20222:06 pmRNSSecond Price Monitoring Extn
3rd Oct 20222:00 pmRNSPrice Monitoring Extension
3rd Oct 202212:22 pmRNSPublication of Prospectus & Total Voting Rights
30th Sep 20224:18 pmRNSTotal Voting Rights
29th Sep 20227:00 amRNS2022 Interim Results
22nd Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR
14th Sep 20227:00 amRNSExercise of Warrants, Issue of Equity and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.